
Pharmacists Key to Mavacamten REMS, Interaction Checks in Teens
Joseph Rossano, MD, MS, outlines how pharmacists support the mavacamten REMS, dose adjustments, and interaction screening for adolescents with oHCM.
In an interview with Pharmacy Times, Joseph Rossano, MD, MS, FAAP, FACC, chief of cardiology at Children’s Hospital of Philadelphia, discussed the role of pharmacists in caring for adolescents with
Looking ahead, Rossano pointed to encouraging signals that the heart may be favorably remodeling, including improved diastolic function, marked reductions in troponin and natriuretic peptides, and reduced wall thickness. Still, follow-up spanning years to decades is needed, along with real-world data in larger populations. He expressed hope that more targeted therapies for pediatric patients will follow.
Related to this article








